This brand name is authorized in Nigeria.
The drug EM-VIT-C contains one active pharmaceutical ingredient (API):
1
|
UNII
PQ6CK8PD0R - ASCORBIC ACID
|
|
Ascorbic acid, coupled with dehydroascorbic acid to which it is reversibly oxidised, has a variety of functions in cellular oxidation processes. Ascorbic acid is required in several important hydroxylations, including the conversion of proline to hydroxyproline and appears to have an important role in metal ion metabolism, including the gastrointestinal absorption of iron and its transport between plasma and storage organs. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| 04-0262 | Syrup | EM-VIT C SYRUP SYRUP 100 mg | EM-VIT C SYRUP 04-0262 EM-VIT C SYRUP Vitamin C 100mg Drugs BLOOD AND BLOOD FORMING ORGANS Drugs EMZOR PHARMACEUTICAL INDUSTRIES LIMITED, plot 3c blk aswani market road isolo 14805555 EMZOR PHARMACEUTICALS INDUSTRIES LTD, NO 10 KOLAWOLE SHONIBARE STREET, AJAO ESTATE,LAGOS, Nigeria 2/23/2023 2/22/2028 | 23/02/2023 |
| 04-4053 | Chewable tablet | Em-Vit-C Chewable Tablet TAB_CHEW 100 mg 1 x 100's; 1 x 1000's (in plastic containers) | Chewable tablet | 28/08/2024 |
| A7-4436 | Chewable tablet | Em-Vit-C 500 Chewable Tablet TAB_CHEW 500 mg 3 x 10's | Chewable tablet | 28/09/2020 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | 04-0262, 04-4053, A7-4436 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.